In addition to adopting these solutions, Radboudumc is launching a multi-year research project with other hospitals to demonstrate AI’s impact across Dutch healthcare in both academic and general public hospital environments. In line with Radboudumc’s key principle of “Turning ambition to impact”, the study will evaluate the impact of these tools on workflow enhancements, setting the stage for broader adoption in the Netherlands and potentially across Europe.

“The deployment of Annalise into clinical practise at Radboudumc and other hospitals enables world leading research to be conducted and demonstrates the clinical and economic benefit Annalise is providing. It’s a seed that we are sowing, the fruits of which could reshape the future of healthcare in the Netherlands—and perhaps the continent,” said Dimitry Tran, deputy CEO and co-founder, Annalise.ai. As a primary reference site for hospitals across the Netherlands and Europe, Radboudumc is poised to lead the new era of integrating AI into clinical practice, strengthening the foundation for a more efficient, accurate, and patient-centered healthcare system.

Back to HCB News

Hospital Installs Homepage